International Healthcare Pricing for Self-Funded Employers
Employer health benefit costs reached $18,500 per employee in 2025, a 6.7% increase and the steepest annual rise since 2011 (Mercer, 2025 (opens in new tab)). US commercial hospital prices remain at 254% of Medicare (RAND, 2024 (opens in new tab)). Published procedure pricing from JCI-accredited international facilities is available as a plan resource through a provider-funded marketplace model.
44% of large employers offer or plan to offer a medical travel benefit (Mercer, 2022). International JCI-accredited hospitals publish pricing at 40-80% below US commercial equivalents for the same procedure categories. The marketplace provides published pricing and direct consultation booking. Providers fund the platform through commissions on completed treatment.
Employer Health Insurance Cost Trends, 2020-2026
RAND's 2024 Hospital Price Transparency Study (opens in new tab) found that employers and private insurers paid hospitals an average of 254% of what Medicare would have paid for the same services. In some states, it's over 300%. That premium doesn't correspond to superior outcomes. The Commonwealth Fund's Mirror Mirror 2024 report (opens in new tab) ranks the US last among 10 high-income nations on health system performance, despite spending nearly double the OECD average. The US ranks second in clinical care process quality. The problem is price and access, not capability.
Average total health benefit cost per employee reached $18,500 in 2025, a 6.7% year-on-year increase and the steepest since 2011 (Mercer, 2025 (opens in new tab)). The Milliman Medical Index (opens in new tab) puts total healthcare cost for a family of four at $35,119 in 2025. Nearly triple two decades ago.
Where Spending Concentrates
Willis Towers Watson's 2025 Best Practices in Healthcare Survey (opens in new tab) (417 employers, 5 million employees) found the top 1% of plan members drive approximately 28% of total plan costs. The AHRQ Medical Expenditure Panel Survey (opens in new tab) reports the top 5% of spenders account for 49.7% of all healthcare expenditures, with top-1% spenders averaging $147,071 per year. For a self-insured employer with 1,000 lives, that means 8 to 12 high-cost claimants per year can represent 20-30% of total claims. Knee replacements. Spinal fusions. Cardiac bypass. Bariatric surgery. These are the procedures most likely to breach specific stop-loss thresholds.
Domestic Cost Containment Plateau
Reference-based pricing generates friction with providers. Narrow networks generate friction with employees. Surgical bundling reduces the unit cost but doesn't alter the base pricing dynamic. About half of US metropolitan areas are served by one or two health systems for all inpatient commercial hospital care (Peterson-KFF (opens in new tab)). That concentration is the structural explanation for the 254% figure.
The 2024 iFHP International Healthcare Cost Comparison Report (opens in new tab) illustrates the differential concretely: median coronary bypass surgery cost in the US is $89,094. In Australia: $17,741. In Spain: $10,734. The pricing differential is structural, arising from market concentration in the US versus competitive pricing internationally.
44% of large employers offer or plan to offer a medical travel benefit (Mercer, 2022, 701 organisations). Willis Towers Watson's 2025 survey found 35% of large employers will offer a non-traditional medical plan in 2026. International pricing data introduces a reference point from a fundamentally different market for self-insured employers evaluating cost containment alternatives.
US vs International Published Pricing
Published prices for the procedures that drive plan costs. International prices represent standard published rates at JCI-accredited facilities.
| Procedure | US Commercial Price | International Price Examples | US Source | Int'l Source |
|---|---|---|---|---|
| Knee Replacement | $35,000-$50,564 | $6,600-$17,000 | RAND 2024, Trilliant Health | iFHP 2024, Sylk Health marketplace |
| Hip Replacement | $28,167-$50,564 | $7,200-$17,000 | RAND 2024, Trilliant Health | iFHP 2024, Sylk Health marketplace |
| Spinal Fusion | $80,000-$150,000 | $9,500-$25,000 | RAND 2024, ACS | iFHP 2024, Sylk Health marketplace |
| Cardiac Bypass (CABG) | $57,240-$123,000 | $7,900-$27,000 | JAHA 2024, RAND 2024 | iFHP 2024, Sylk Health marketplace |
| Bariatric Surgery | $17,000-$35,000 | $4,500-$10,000 | ASMBS/ACS | iFHP 2024, World Population Review 2025 |
| Heart Valve Replacement | $71,312-$200,000 | $8,000-$33,200 | RAND 2024, Trilliant Health | iFHP 2024, Sylk Health marketplace |
Illustrative only. Published international prices represent facility and surgeon fees; total episode cost (including travel, lodging, companion expenses, and domestic follow-up) varies by destination. Actual costs depend on provider selection and case complexity. Sylk Health doesn't set, verify, or guarantee provider pricing.
Domestic Centers of Excellence: The Walmart and Lowe's Model
92% of large employers have adopted at least one type of COE, according to the Business Group on Health's 2024 survey (opens in new tab). Walmart, Lowe's, McKesson, GE, Boeing, and JetBlue all route employees to designated domestic providers for high-cost procedures. Elizabeth Mitchell, President of the Purchaser Business Group on Health (representing approximately 40 employers spending $350B annually), noted: "Getting access to price and quality data to effectively evaluate whether employers and families are paying a fair price for health care services is still too hard."
Peer-Reviewed Evidence
Whaley et al. (Health Affairs, 2021) (opens in new tab) studied 2,372 procedures across 8 self-insured employers between 2016 and 2020. The analysis found an average $4,229 reduction in episode price (10.7%), with spinal fusion savings of 29.1% ($29,164 per episode) and joint replacement savings of 18.4%. For every $1 in copayments waived, employers saved $7. Thirty percent of referred patients received recommendations for conservative treatment instead of surgery.
Walmart COE Programme Outcomes
Walmart's programme routes employees to designated hospitals for spine surgery, joint replacement, and cardiac care. Travel and lodging are covered. The programme is voluntary. According to Woods, Slotkin, and Coleman writing in Harvard Business Review (March 2019) (opens in new tab): 95% reduction in 30-day readmission rates for spine surgery (3 per 1,000 at COE sites versus 65 per 1,000 elsewhere), 2.6 weeks faster return to work, and 70% lower readmission rates for joint replacements. Of roughly 2,300 employees referred for spine evaluation, 54% received non-surgical treatment.
Lowe's and PBGH Coalition
Lowe's reported 700+ employees used its COE programme with 20-30% cost reduction versus prior bundled rates, with roughly 30% of surgical candidates redirected to conservative care.
Methodological Counterpoint
A 2013 study by Mehrotra et al. in Medical Care (opens in new tab), analysing over 85,000 spinal procedures across 369 insurer-designated COEs, found no significant differences in complication rates, readmission rates, or costs. That study evaluated the older volume-based designation model. The employer-directed bundled-payment model with second-opinion gatekeeping that Whaley et al. studied in 2021 is a different approach producing materially different results.
International Pricing in Context
Domestic COE programmes reduce per-procedure cost by 15-30% versus general in-network pricing. Carrum Health, whose outcomes have been independently validated by RAND, reports up to 45% savings per surgical episode. These programmes still operate within US commercial pricing. International JCI-accredited providers publish pricing at substantially larger differentials for the same procedure categories. The Sylk Health marketplace lists published pricing from JCI-accredited and equivalent nationally accredited international providers across 1,954 procedures. Members compare pricing and book consultations directly. The prices are visible before any interaction occurs.
ERISA Plan Design and Fiduciary Context
Stern v. JPMorgan (2026) (opens in new tab) confirmed that plan design choices are settlor functions, not fiduciary acts. Cunningham v. Cornell (2025) (opens in new tab) shifted the burden: defendants must now prove fees are reasonable. The DOL's FAB 2026-01 (opens in new tab) reinforced that ERISA is a law of process, not results.
Employers who document that they evaluated pricing alternatives demonstrate the procedural diligence ERISA requires. International pricing data is one input for that evaluation.
Regulatory context only. Sylk Health isn't an ERISA fiduciary and doesn't provide legal or fiduciary advice. Consult ERISA counsel for plan-specific guidance.
Integration with Existing Benefits Architecture
The marketplace operates alongside existing provider arrangements, TPA infrastructure, PBM contracts, and domestic COE programmes. It doesn't replace any existing plan component. Adding the directory requires no changes to existing benefits administration workflows.
No eligibility file exchange. Sylk Health doesn't receive census data, eligibility files, or member rosters. Employees access the directory directly. Sylk Health can't identify which employees belong to a specific plan.
Minimal data footprint. Sylk Health collects an email address and an auto-assigned ID. No names, no demographics, no medical history, no insurance information. A BAA is not expected to be required based on this data posture.
No technology integration. No API connections, no SSO, no data feeds. Standard web browser access.
No TPA renegotiation. International claims can be processed through existing out-of-network or COE reimbursement pathways.
Provider-funded model. Sylk Health is paid by providers on completed treatment. No platform fee, subscription, or per-member charge to the plan.
Plan members gain access to a directory of JCI-accredited international providers with published pricing for 1,954 procedures. The plan gains a documented international pricing reference point for high-cost procedures, and members who elect to complete treatment internationally may generate measurable plan savings depending on utilisation and provider pricing.
Target Demographics: Self-Insured Employers, 500-5,000 Employees
67% of covered workers are enrolled in self-funded plans, rising to 80% at firms with 200+ employees (KFF, 2025). The following employer profiles represent the strongest alignment with published international pricing as a plan resource.
Self-funded plans, 500-5,000 employees. Large enough to have a meaningful number of high-cost procedures per year. Small enough that each case visibly moves plan performance.
Employers already running domestic COE programmes. The procurement framework, employee communication model, and travel-benefit infrastructure already exist. The marketplace is an additional resource, not a new capability.
ESOPs and employee-owned companies. Plan savings flow directly back to employees through improved plan economics.
Employers with a distributed or remote workforce. Employees already travel for domestic COE procedures. International travel is a smaller incremental step.
Multi-national employers with employees who have ties to specific countries. Some employees have family, language fluency, or comfort with international healthcare systems.
Not a Fit Today
- Fully insured plans without self-funded carve-outs
- Employers with fewer than 200 employees
- Organisations that can't amend their plan document
Implementation Timeline and Requirements
Implementation from initial review to member access typically takes less than 30 days. The process involves one legal review, one TPA notification, and one employee communication. No technical integration, no data exchange, and no system configuration.
Review plan structure and determine positioning: informational resource or formal plan benefit.
ERISA counsel reviews plan-document implications. TPA notified that international claims may be submitted. No TPA renegotiation required.
Employee communication materials finalised. Internal review of marketplace fact sheet completed.
Resource announced to employees. Members access the marketplace immediately. No enrolment step required.
Data Posture and Privacy
What Sylk Health Collects
- An auto-assigned ID string (not linked to any employer or plan identifier)
- The email address the employee provides (which can be a personal email)
- The procedure the employee selected
That's the entire data footprint.
What Sylk Health Never Collects
- Employee name, demographics, or date of birth
- Medical history or diagnosis
- Insurance information or member ID
- Employer name or plan identifier
- Any data that links the employee to a specific organisation
Sylk Health can't identify which employees belong to a specific plan. An employee using the marketplace is indistinguishable from any other member of the public. BAA not expected to be required. No eligibility file exchange. No member data exchange in either direction.
Data posture. Sylk Health doesn't receive, store, or process protected health information (PHI) as defined under HIPAA. The data collected is limited to an auto-assigned ID, an email address, and procedure selection. Plan sponsors should confirm with their own privacy counsel.
Revenue Model
Providers pay Sylk Health a commission on completed treatment. The commission is drawn from provider revenue and is not added to the member's price. No fee is charged to the plan sponsor, carrier, member, or referring consultant. No subscription, per-member charge, implementation fee, or contract is required.
Frequently Asked Questions
Centers of excellence (COE) programmes route employees to designated high-volume hospitals for specific procedures, typically with bundled pricing, waived copays, and covered travel. According to the Business Group on Health's 2024 survey, 92% of large employers have adopted at least one COE programme. Whaley et al. (Health Affairs, 2021) found employer-directed COE programmes reduced per-episode costs by $4,229 (10.7%) across 2,372 procedures at 8 self-insured employers. Walmart, Lowe's, McKesson, Boeing, and JetBlue all operate domestic COE programmes.
Making an international provider directory available to employees is a plan-design decision. Under ERISA, that's a settlor function. Settlor functions aren't subject to ERISA's fiduciary duties. The decision is structurally similar to adding a domestic COE programme or a cost-comparison tool.
After Stern v. JPMorgan and Cunningham v. Cornell, fiduciaries face increasing scrutiny on whether they're paying reasonable compensation for medical services. The DOL's FAB 2026-01 reinforces that ERISA is "a law of process, not results," and that employers who document their evaluation of pricing alternatives demonstrate the process-based diligence the statute requires.
Consult ERISA counsel for plan-specific guidance. Sylk Health doesn't provide legal advice.
It depends on positioning. If the marketplace is available as an informational resource (similar to a cost-comparison tool), no amendment is required. If the plan formally recognises international care as a covered benefit, a plan-document amendment and Summary of Material Modifications are needed. ERISA counsel can advise on the appropriate approach.
The stop-loss carrier should be notified. Many carriers cover international claims at JCI-accredited facilities, particularly when the per-case cost is substantially below the domestic equivalent, though coverage varies by policy terms. Because international procedures are typically priced well below US rates, the net effect may reduce the likelihood of hitting specific and aggregate stop-loss thresholds.
Plan sponsors should discuss with their stop-loss carrier or broker before the next renewal cycle.
All medical procedures carry risk. Employees who proceed with treatment contract directly with the treating provider. Post-treatment care is between the employee and the provider. Employees should discuss complication protocols with the provider before proceeding.
The employee's domestic plan continues to cover follow-up care according to its terms. JCI-accredited hospitals maintain clinical records that can be shared with US providers. Many patients who travel for procedures independently purchase complication coverage from third-party insurers.
Sylk Health doesn't manage complications, follow-up, or any aspect of clinical care.
HSA and FSA funds can generally be used for qualified medical expenses under IRC Section 213(d). Medical care at an accredited facility in another country can qualify. Travel costs are subject to IRS rules and limitations ($50/night lodging cap per person under current rules). Plan sponsors should consult a tax adviser.
If international marketplace access is part of the plan document as a covered benefit, COBRA continuation applies. If it's offered as an informational resource outside the plan document, COBRA doesn't apply. ERISA counsel can clarify the plan-specific implications.
Minimal changes. International claims can be processed through existing out-of-network or COE reimbursement pathways. No system integration, no new data feeds, no eligibility file exchange with Sylk Health. A brief notification to the TPA is sufficient.
Joint Commission International is the international arm of the Joint Commission, which accredits US hospitals. JCI evaluates hospitals against international patient safety and quality standards across more than 1,200 measurable elements. JCI-accredited hospitals undergo on-site surveys every three years. As of 2026, roughly 600 hospitals in over 70 countries hold JCI accreditation. Every provider listed on the Sylk Health marketplace holds current JCI accreditation or equivalent national accreditation.
No. Sylk Health is a directory and booking layer. Employees see published prices, wait times, and consultation availability. They compare options and choose a provider themselves. Sylk Health doesn't rank, feature, match, or recommend providers.
Nothing. Sylk Health is paid by providers on completed treatment. There's no platform fee, subscription fee, per-member fee, or implementation fee charged to the employer, plan, or employee.
Then the resource cost the plan nothing. No minimum commitment, no usage threshold, no penalty. The marketplace stays available. The pricing data also serves as documentation that the plan evaluated international pricing alternatives for high-cost procedures.
Providers upload their own pricing to the marketplace. These are the prices providers are willing to publish, not estimates or averages. Because patients see and compare prices from multiple providers for the same procedure, providers have a structural incentive to keep listed prices current and competitive. Sylk Health doesn't set, negotiate, or guarantee prices.
Published Pricing: 1,954 International Procedures
Pricing data from JCI-accredited international facilities, organised by procedure category.
Sylk Health operates an online marketplace listing JCI or equivalent nationally accredited international healthcare providers. Sylk Health is not a healthcare provider, insurance company, health plan, or clinical service. Sylk Health does not provide medical advice, coordinate care, arrange travel, or manage clinical outcomes. All providers listed on the marketplace are independent entities. Patients contract directly with providers. Provider-listed prices are published by the providers themselves and may change without notice. Sylk Health does not set, verify, or guarantee provider pricing. Actual costs depend on individual case complexity, provider selection, and treatment requirements. Content on this page is for informational purposes only and does not constitute medical, legal, actuarial, or fiduciary advice. Plan administrators, carriers, and healthshare ministries should consult their own qualified advisors before making decisions based on information presented here. Sylk Health has no affiliation with any third-party organisation referenced on this page unless explicitly stated.